The troubled genomics company has been in a downward spiral ever since it suffered an unfortunate data breach in 2023. The company has since endured a maelstrom of conflict and controversy, including ...

The 23andMe case is not just about one company in financial trouble. It raises broader questions about the future of genetic privacy in a rapidly digitizing world. Direct-to-consumer DNA services ...